Protease-specific nanosensors for magnetic resonance imaging

Bioconjugate Chemistry

Volumn 19, Issue 12, 2008, Pages 2440-2445

  Schellenberger, Eyk ^a   Rudloff, Franziska ^a   Warmuth, Carsten ^a   Taupitz, Matthias ^a   Hamm, Bernd ^a   Schnorr, Jörg ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IRON OXIDES; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; NANOSENSORS;

A-STABLE; ENZYMES ACTIVITY; IN-VIVO; IN-VIVO IMAGING; IRON OXIDE PARTICLES; MATRIX METALLOPROTEINASE-9; PROTEASE ACTIVITIES; RELAXIVITY; SMART PROBES; TUMOR PROGRESSIONS;

ENZYME ACTIVITY;

COPOLYMER; GELATINASE B; IRON OXIDE; NANOPARTICLE; PROTEINASE;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HYDRODYNAMICS; IMAGE ANALYSIS; INFLAMMATION; NANOSENSOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; TUMOR GROWTH;

EID: 58149096269     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800330k     Document Type: Article

References (22)

1. Weissleder, R., Tung, C. H., Mahmood, U., and Bogdanov, A. J. (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotechnol. 17, 375-378.
2. Ntziachristos, V., Ripoll, J., Wang, L. V., and Weissleder, R. (2005) Looking and listening to light: the evolution of whole-body photonic imaging. Nat. Biotechnol. 23, 313-320.
3. Weissleder, R., and Pittet, M. J. (2008) Imaging in the era of molecular oncology. Nature 452, 580-589.
4. Louie, A. Y., Hüber, M. M., Ahrens, E. T., Rothbächer, U., Moats, R., Jacobs, R. E., Fraser, S. E., and Meade, T. J. (2000) In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 18, 321-325.
5. Bogdanov, A., Matuszewski, L., Bremer, C., Petrovsky, A., and Weissleder, R. (2002) Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. Mol. Imaging 1, 16-23.
6. Perez, J. M., Josephson, L., O'Loughlin, T., Hogemann, D., and Weissleder, R. (2002) Magnetic relaxation switches capable of sensing molecular interactions. Nat. Biotechnol. 20, 816-820.
7. Taupitz, M., Wagner, S., Schnorr, J., Kravec, I., Pilgrimm, H., Bergmann-Fritsch, H., and Hamm, B. (2004) Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging. Invest. Radiol. 39, 394-405.
8. Chen, J., Tung, C. H., Allport, J. R., Chen, S., Weissleder, R., and Huang, P. L. (2005) Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction. Circulation 111, 1800-1805.
9. Kridel, S. J., Chen, E., Kotra, L. P., Howard, E. W., Mobashery, S., and Smith, J. W. (2001) Substrate hydrolysis by matrix metalloproteinase-9. J. Biol. Chem. 276, 20572-20578.
10. Hu, J., Van den Steen, P. E., Sang, Q. X., and Opdenakker, G. (2007) Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat. Rev. Drug Discovery 6, 480-498.
11. Bremer, C., Tung, C. H., and Weissleder, R. (2001) In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat. Med. 7, 743-748.
12. DeLano, W. L. (2002) The PyMOL Molecular Graphics System, DeLano Scientific, USA.
13. Josephson, L., Kircher, M. F., Mahmood, U., Tang, Y., and Weissleder, R. (2002) Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjugate Chem. 13, 554-60.
14. Moghimi, S. M., and Szebeni, J. (2003) Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 42, 463-478.
15. Shi, B., Fang, C., and Pei, Y. (2006) Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity. J. Pharm. Sci. 95, 1873-1887.
16. Wagner, S., Schnorr, J., Pilgrimm, H., Hamm, B., and Taupitz, M. (2002) Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization. Invest. Radiol. 37, 167-177.
17. Thiesen, B., and Jordan, A. (2008) Clinical applications of magnetic nanoparticles for hyperthermia. Int. J. Hyperthermia 1-8.
18. Koh, I., Hong, R., Weissleder, R., and Josephson, L. (2008) Sensitive NMR sensors detect antibodies to influenza. Angew. Chem., Int. Ed. Engl. 47, 4119-4121.
19. Kaufels, N., Korn, R., Wagner, S., Schink, T., Hamm, B., Taupitz, M., and Schnorr, J. (2008) Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases. Invest. Radiol. 43, 496-503.
20. Schnorr, J., Wagner, S., Abramjuk, C., Drees, R., Schink, T., Schellenberger, E. A., Pilgrimm, H., Hamm, B., and Taupitz, M. (2006) Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits. Radiology.
21. Schellenberger, E., Schnorr, J., Reutelingsperger, C., Ungethum, L., Meyer, W., Taupitz, M., and Hamm, B. (2008) Linking proteins with anionic nanoparticles via protamine: ultrasmall protein-coupled probes for magnetic resonance imaging of apoptosis. Small 4, 225-230.
22. Browner, M. F., Smith, W. W., and Castelhano, A. L. (1995) Matrilysin-inhibitor complexes: common themes among metalloproteases. Biochemistry 34, 6602-6610.